- Bonnevie O. Changing demographs of peptic ulcer disease. Dig Dis Sei 1985, 30(Nov suppl):8S–14S
- Langman MJS. The tide of peptic ulcer. Scand J Gastroenterol 1980, 15(suppl 63), 149–156
- Sonnenberg A. Disability pensions due to peptic ulcer in Germany between 1953 and 1983. Am J Epidemiol 1985, 122, 106–111
- Black JW, Duncan WF, Durant CJ, et al. Definition and antagonism of histamine H2-receptors. Nature 1972, 236, 385–390
- Boyd EJS, Wilson JA, Wormsley KG. Safety of ranitidine maintenance treatment of duodenal ulcer. Scand J Gastroenterol 1984, 19, 394–400
- Martin L, Lewis N. Peptic ulcer cases reviewed after 10 years. Lancet 1949, 2, 1115–1120
- Krause U. Long term results of medical and surgical treatment of peptic ulcer. Acta Chir Scand 1963(suppl 310), 5–111
- Krag E. Long-term prognosis in medically treated peptic ulcer. Acta Med Scand 1966, 180, 657–668
- Malmros H, Hiertonn T. Post-investigation of 687 medically treated cases of peptic ulcer. Acta Med Scand 1949, 133, 229
- Pulvertaft CN. Incidence of natural history of gastric and duodenal ulcer. Postgrad Med J 1968, 44, 597–602
- Hallenbeck G. The natural history of duodenal ulcer disease. Surg Clin North Am 1976, 56, 1235
- Fry J. Peptic ulcer: a profile. Br Med J 1964, 2, 808–812
- Greibe J, Bugge P, Gjorup T, Lauritzen T, Bonnevie O, Wulff HR. Long term prognosis of duodenal ulcer: follow-up study and survey of doctor’s estimates. Br Med J 1977, 2, 1572–1574
- Blackwood WS, Maudgal DP, Northfield TC. Prevention by bedtime cimetidine of duodenal ulcer relapse. Lancet 1978, 1, 626–627
- Burland WL, Hawkins BW, Beresford J. Cimetidine treatment for the prevention of recurrence of duodenal ulcer: an international collaborative study. Postgrad Med J 1980, 56, 173–176
- Hetzel DJ, Hecker R, Shearman DJC. Long term treatment of duodenal ulcer with cimetidine. Med J Aust 1980, Nov 29, 612–614
- Lane MR, Lee SP. Recurrence of duodenal ulcer after medical treatment. Lancet 1988,1,1147–1149
- Ryle JA. The natural history of duodenal ulcer. Lancet 1932, 1, 327–334
- Stolte JB. Gross bleeding from the digestive tract. II. The frequency of manifest bleeding in peptic ulcer, with regard to the duration of the disease and the age of the diseased. Acta Med Scand 1944, 116, 584
- Viskum A. A comparison of the course of the disease among patients with gastric ulcer, duodenal ulcer, and ulcer dyspepsia without ulcer demonstrable by X-ray. Dan Med Bull 1976, 23, 129
- Elashoff JD, Van Deventer G, Reedy TJ, et al. Long term follow-up of duodenal ulcer patients. J Clin Gastroenterol 1983, 5, 509–515
- Boey J, Lee NW, Koo J, et al. Immediate definitive surgery for perforated duodenal ulcers. Ann Surg 1982, 196, 338
- Wormsley KG. In: Horrobin DF, ed. Duodenal ulcer. Vol. II, Chapter 11. Churchill Livingstone, Eden Press Inc, Edinburgh, 1979
- Hoffmann J, Hauch O, Jensen H-E. Comparison between the sexes of the results of parietal cell vagotomy for duodenal ulcer 11–18 years after surgery. JR Coll Surg Edin 1988, 33, 179–181
- Stabile BE, Passaro E. Recurrent peptic ulcer. Gastroenterology 1976, 70, 124–135
- Boyd EJS, Penston JG, Johnston DA, Wormsley KG. Does maintenance therapy keep duodenal ulcers healed? Lancet 1988, 1, 1324–1327
- Berstad A, Aadland E, Carlsen E, Myren J, Semb LS, Krause-Jensen A. Maintenance treatment of duodenal ulcer patients with a single bedtime dose of cimetidine. Scand J Gastroenterol 1979, 14, 827–831
- Salera M, Taroni F, Miglioli M, et al. Long term effects and after-effects of cimetidine in duodenal ulcer patients. Ital J Gastroenterol 1979, 11, 49–52
- Sontag S, Graham DY, Belsito A, et al. Cimetidine, cigarette smoking and recurrence of duodenal ulcer. N Engl J Med 1984, 311, 689–693
- Bianchi Porro G, Petrillo M. Long term prophylactic treatment with cimetidine in duodenal ulceration. Ital J Gastroenterol 1979, 11, 181–183
- Sonnenberg A, Muller-Lissner SA, Vogel E, et al. Predictors of duodenal ulcer healing and relapse. Gastroenterology 1981, 81, 1061–1067
- Hameeteman W, Tytgat GN, Wiersinga W, v d Boomgard DM, Dees J. A four year study of cimetidine maintenance treatment in peptic ulcer disease [Abstract], Neth J Med 1986, 29, 29
- Walan A, Bianchi Porro G, Hentschel E, Bardhan KD, Delattre M. Maintenance treatment with cimetidine in peptic ulcer disease for up to 4 years. Scand J Gastroenterol 1987, 22, 397–405
- Bardhan KD. Six years of continuous cimetidine treatment in peptic ulcer disease: efficacy and safety. Aliment Pharmacol Ther 1988, 2, 395–405
- Mekel RCPM. Long term treatment with cimetidine. S Afr Med J 1978, 54, 1089–1091
- Gudmand-Hoyer E, Jensen KB, Krag E, et al. Prophylactic effect of cimetidine in duodenal ulcer disease. Br Med J 1978, 1, 1095–1097
- Bodemar G, Walan A. Maintenance treatment of recurrent peptic ulcer by cimetidine. Lancet 1978, 1, 403–407
- Dronfield MW, Batchelor AJ, Larkworthy W, Langman MJS. Controlled trials of maintenance cimetidine treatment in healed duodenal ulcer: short and long term effects. Gut 1979, 20, 526–530
- Fitzpatrick WJF, Blackwood WS, Northfield TC. Bedtime cimetidine maintenance treatment: optimum dose and effect on subsequent natural history of duodenal ulcer. Gut 1982, 23, 239–242
- Anglo-Irish Long Term Cimetidine Study Group. Prophylaxis against duodenal and gastric ulcer recurrence using maintenance treatment with cimetidine: 4-year results [Abstract]. Gastroenterology 1985, 88, 1307
- Alstead EM, Ryan FP, Holdsworth CD, Ashton MG, Moore M. Ranitidine in the prevention of gastric and duodenal ulcer relapse. Gut 1983, 24, 418–420
- Silvis SE. Results of the US ranitidine maintenance trials. Am J Med 1984, 77(suppl 5B), 33–38
- Hovdenak N, Johansen J, Lange O, Skjølingstad R, Qvigstad T, Ødegaard S. Ranitidine in the treatment and prophylaxis of duodenal ulcer [Abstract], Scand J Gastroenterol 1985, 20(suppl 113), 32
- Kozarek R, Berenson M, Berkowitz J, et al. Maintenance therapy with ranitidine following healing of duodenal ulcer. Curr Ther Res 1985, 38, 341–351
- Lombardo L, Babando GM, De La Pierre M, et al. Long term treatment of duodenal ulcer with ranitidine: an endoscopic, biochemical and clinical trial. Panminerva Med 1983, 25, 105–108
- Lee FI, Fielding JD, Holmes GKT, et al. Ranitidine: prophylaxis of duodenal ulcer recurrence. Hepatogastroenterol 1984, 31, 85–87
- Blasi A, Magiameli A, Castelli G, et al. Long term (24-month) ranitidine in prevention of duodenal ulcer relapse: comparison of continuous and seasonal treatment. Ital J Gastroenterol 1987, 19, 141–144
- Susi D, Ianetti G, Di Pietro AM. Long term therapy of peptic ulcer: our experience with ranitidine after 4 years. Ital J Gastroenterol 1987, 69S
- Bolin TD, Billington BP, Davis AE. Comparison of ranitidine and cimetidine as maintenance therapy in the prevention of duodenal ulcer recurrence [Abstract]. Aust NZ J Med 1983, 13, 440
- Walt RP, Hunt RH, Misiewicz JJ, et al. Comparison of ranitidine and cimetidine maintenance treatment of duodenal ulcer. Scand J Gastroenterol 1984, 19, 1045–1047
- Bresci G, Capria A, Federici G, Rindi G, Geloni M. Prevention of relapse with various anti-ulcer drugs. Scand J Gastroenterol 1986, 21(suppl 121), 58–62
- Gough KR, Bardhan KD, Crowe JP, Korman MG, Lee FI, Reed PL Ranitidine and cimetidine in prevention of duodenal ulcer relapse. Lancet 1984, 2, 659–662
- Kurata JH, Koch GG, Nogawa AN. Comparison of ranitidine and cimetidine ulcer maintenance therapy. J Clin Gastroenterol 1987, 9(6), 644–650
- Van Deventer GM, Elashoff JD, Reedy TJ, Scheidman D, Walsh JH. A randomised study of maintenance therapy with ranitidine to prevent the recurrence of duodenal ulcer. N Engl J Med 1989, 320, 1113–1119
- Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958, 53, 457–481
- Peto R, Pike M, Armitage P, et al. Design and analysis of randomised clinical trials requiring prolonged observation of each patient. Br J Cancer 1977, 35, 1–39
- Strum WB. Prevention of duodenal ulcer recurrence. Ann Intern Med 1986, 105, 757–761
- Orlando RC. Peptic ulcer: factors influencing recurrence. J Clin Gastroenterol 1987, 9(suppl 1), 2–7
- Cox DR. Regression models and life tables. J R Stat Soc 1972, Series B, 34, 187–220
- Ippoliti A, Elashoff J, Valenzuela J, et al. Recurrent ulcer after successful treatment with cimetidine or antacid. Gastroenterology 1983, 85, 875–880
- Battaglia G, Di Mario F, Piccoli A, et al. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. Am J Gastroenterol 1984, 79, 831–834
- Massarrat S, Heuser E, Hausmann L, Schubotz R. Langzeitprophylaxe des Ulcus duodeni mit Cimetidin. Dtsch Med Wochenschr 1982, 107, 1085–1088
- Korman MG, Hansky J, Eaves ER, Schmidt GT. Influence of cigarette smoking on healing and relapse in duodenal ulcer disease. Gastroenterology 1983, 85, 871–874
- Bardhan KD, Saul DM, Edwards JL, et al. Double blind comparison of cimetidine and placebo in the maintenance of healing of chronic duodenal ulceration. Gut 1979, 20, 158–162
- Boyd EJS, Wilson JA, Wormsley KG. Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine. Scand J Gastroenterol 1983, 18, 193–200
- Bissette J, Carr G, Koch GG, Adams KF, Sheps DS. Analysis of (events/time at risk) ratios from two-period crossover studies. Proc Biopharmaceut Sect Am Stat Assoc 1986, 104
- Moshal MG, Spitaels J-M, Manion GL. Doubleblind placebo controlled evaluation of one year therapy with sucralfate in healed duodenal ulcer. Scand J Gastroenterol 1983, 18(suppl 83), 57–59
- Classen M, Bethge H, Brunner G, et al. Effect of sucralfate on peptic ulcer recurrence: a controlled double blind multicentre study. Scand J Gastroenterol 1983, 18(suppl 83), 61–68
- Jorde R, Burhol PG. Asymptomatic peptic ulcer disease. Scand J Gastroenterol 1987, 22, 129–134
- Ihamaki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Scand J Gastroenterol 1979, 14, 801–812
- Lanza FL, Davis RE. Asymptomatic ulcers and erosions occur in normal volunteer populations [Abstract], Am J Gastroenterol 1984, 79, 820
- Araki S, Goto Y. Peptic ulcer in male factory workers: A survey of prevalence, incidence, and aetiological factors. J Epidemiol Community Health 1985, 39, 82–85
- Akdamar K, Ertan A, Agrawal NM, McMahon FG, Ryan J. Upper gastrointestinal endoscopy in normal asymptomatic volunteers. Gastrointest Endosc 1986, 32, 79–80
- Rypkins EB, Sarfeh IJ, Collins-Irby D, Stemmer EA, Juler GL, Thrower S. Asymptomatic peptic ulcer disease in patients undergoing major elective operations: a prospective endoscopic study. Am J Gastroenterol 1988, 83, 927–929
- Kaneko E, Ooi S, Ito G, Honda N. Natural history of duodenal ulcer detected by the gastric mass surveys in men over 40 years of age. Scand J Gastroenterol 1989, 24, 165–170
- Schiller KF, Truelove SC, Williams DG. Haematemesis and melaena, with special reference to factors influencing the outcome. Br Med J 1970, 2, 7–14
- Coggon D, Langman MJS, Spiegelhalter D. Aspirin, paracetamol, and haematemesis and melaena. Gut 1982, 23, 340–344
- Mathewson K, Pugh S, Northfield TC. Which peptic ulcer patients bleed? Gut 1988, 29, 70–74
- Griffen GE, Organ CH. The natural history of the perforated duodenal ulcer treated by suture plication. Ann Surg 1976, 183, 382–385
- Drury JK, McKay AJ, Hutchison JSF, Joffe SN. Natural history of perforated duodenal ulcers treated by suture closure. Lancet 1978, 2, 749–750
- Pounder R. Silent peptic ulceration: deadly silence or golden silence? Gastroenterology 1989,96,626–631
- Butt JH, Barthel JS, Hosakawa MC, Moore RA. NSAIDS: a clinical approach to the problems of gastrointestinal side-effects. Aliment Pharmacol Ther 1988, 2S, 121–129
- Yeomans ND, Elliot SL, Edwards J, Buchanan R, Sturrock D, Smallwood R. Gastroduodenal damage during therapy with non-steroidal antiinflammatory drugs: prevalence in arthritis clinic patients and effect of smoking [Abstract]. Gastroenterology 1988, 94, A510
- Upadhyay R, Howatson A, McKinaly AW, Gemmell C, Sturrock RD, Russell RI. Asymptomatic versus symptomatic gastric ulcers in patients with rheumatoid arthritis receiving non-steroidal antiinflammatory drugs (NSAIDS) [Abstract], Gut 1988, 29, A1443
- Eliakim R, Ophir M, Rachmilewitz D. Duodenal mucosal injury with non-steroidal anti-inflammatory drugs. J Clin Gastroenterol 1987, 9(4), 395–399
- Mellern H, Stave R, Myren J, et al. Symptoms in patients with peptic ulcer and haematemesis and/ or melaena related to the use of non-steroid antiinflammatory drugs. Scand J Gastroenterol 1985, 20, 1246–1248
- Armstrong CP, Blower AL. Peptic ulcer complications and non-steroidal anti-inflammatory drugs [Abstract], Gut 1986, 27, A609
- Boyd EJS, Wilson JA, Wormsley KG. The fate of asymptomatic recurrences of duodenal ulcer. Scand J Gastroenterol 1984, 19, 808–812
- Cargill JM, Saunders JHB, Peden N, Wormsley KG. Very long term treatment of peptic ulcer with cimetidine. Lancet 1978, 2, 1113–1115
- Eastman MC, Gear MWL. Vagotomy and pyloroplasty for gastric ulcers. Br J Surg 1979, 66, 238
- Muhe E, Schick A, Rosch W. Selektive proximale Vagotomie ohne Drainage beim unkomplizierten Duodenalulkus. Forschr Med 1979, 97, 2195
- Muller C, Martinoli S, Allgower M. Die Wirksamkeit der proximal-selectiven Vagotomie beim Gastroduodenlulkus. In: Abstracts of the 48th Annual Meeting, Swiss Society of Gastroenterology, 1983, 54
- Miller R, Jick H. Acute toxicity of aspirin in hospitalised medical patients. Am J Med Sei 1977, 274, 271–279
- Manchester General Practitioner Group. A study of naproxen and ibuprofen in patients with osteoarthritis seen in general practice. Curr Med Res Opin 1984, 9, 41–46
- Billington BP. Observations from New South Wales on the changing incidence of gastric ulcer in Australia. Gut 1965, 6, 121–133
- Piper DW, McIntosh JW, Ariotti DE, Fenton BH, MacLennan R. Analgesic ingestion and chronic peptic ulcer. Gastroenterology 1981, 80, 427–432
- Langman MJS. Ulcer and ulcer complications from NSAIDS: what is the risk? Aliment Pharmacol Ther 1988, 2S, 27–31
- Chalmers TC, Berrier J, Hewitt P, et al. Metaanalysis of RCT as a method of estimating rare complications of NSAIDS. Aliment Pharmacol Ther 1988, 2S, 9–26
- Biljsma JWJ. Treatment of NSAID-induced gastrointestinal lesions with cimetidine: an international multicentre collaborative study. Aliment Pharmacol Ther 1988, 2S, 85–96
- Silvoso GR, Ivey KJ, Butt JH. Incidence of gastric lesions in patients with rheumatic disease on chronic aspirin therapy. Ann Intern Med 1979, 91, 517–520
- Morris AD, Holt SD, Silvoso GR, et al. Effect of anti-inflammatory drug administration in patients with rheumatoid arthritis. An endoscopic assessment. Scand J Gastroenterol 1981, 16, 131–135
- Silvoso GR, Ivey KJ, Lockard OO, Sisk C, Holt S. Prevalence of duodenal lesions in patients with rheumatic diseases on chronic aspirin therapy. Gastrointest Endosc 1980, 26, 5–7
- Berkowitz JM, Adler SN, Sharp JT, Warner CW. Reduction of aspirin-induced gastroduodenal mucosal damage with ranitidine. J Clin Gastroenterol 1986, 8(3), 377–380
- Konturek SJ, Radecki T, Brzozowski T, Piastuki I, Dembinska-Kiec A, Zmuda A. Gastric cytoprotection by prostaglandins, ranitidine and probanthine in rats. Scand J Gastroenterol 1981, 16, 7–12
- Steil D, Ellard KT, Hills LJ, Brooks PM. Protective effect of enprostil against aspirin-induced gastroduodenal mucosal injury in man. Am J Med 1986, 81(suppl 2A), 54–58
- Muller P, Biewer R, Bouzo F, Dammann HG, Schutz E, Simon B. Ranitidine heals gastroduodenal lesions associated with chronic NOSAC therapy in rheumatic patients [Abstract]. Gastroenterology 1987, 92, 1343
- Malchow-Moller A. Treatment of peptic ulcer induced by NSAIDS. Scand J Gastroenterol 1987, 22(suppl 127), 87–91
- Croker J, Cotton P, Boyle A, Kinsella P. Cimetidine for peptic ulcer in patients with arthritis. Ann Rheum Dis 1980, 39, 275–278
- Venables CW. Surgery in the management of the gastric side-effects of NSAIDS. Aliment Pharmacol Ther 1988, 2S, 87–111
- Penston JG, Wormsley KG. Adverse reactions and interactions with H2-receptor antagonists. Med Toxicol 1986, 1, 192–216
- Whitehead R. Mucosal biopsy and gastrointestinal tract. Saunders, Philadelphia, 1973, 14–29
- Rao SS, Krasner N, Thomson TJ. Chronic gastritis — a simple classification. J Pathol 1975, 117, 93–96
- Jass JR, Filipe MI. The mucin profile of normal gastric mucosa, intestinal metaplasia and its variants and gastric carcinoma. Histochem J 1981, 13, 931–939
- Penston JG, Wormsley KG. Achlohydria: hypergastrinaemia: carcinoids—a flawed hypothesis? Gut 1987, 28, 488–505
- Hodges JR, Isaacson P, Wright R. Diffuse enterochromaffin-like (ECL) cell hyperplasia and multiple gastric carcinoids: a complication of pernicious anemia. Gut 1981, 22, 237–241
- Borch K, Renvall H, Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumours in pernicious anemia. Gastroenterology 1985, 88, 638–648
- Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. In: Borg KO, Olbe L, eds. Omeprazole. A survey of preclinical data. Scand J Gastroenterol 1985, 20(suppl 108), 53–69
- Watanabe H, Kinoshita M, Kondo T, et al. Fasting serum gastrin levels in patients with gastroduodenal diseases. Tokushima J Exp Med 1978, 25, 9–15
- Nyren O, Adami HO, Bergstrom R, Gustavsson S, Loof L, Lundqvist G. Basal and food-stimulated levels of gastrin and pancreatic polypeptide in nonulcer dyspepsia and duodenal ulcer. Scand J Gastroenterol 1986, 21, 471–477
- Piris J, Whitehead R. Gastrin cells and fasting serum gastrin levels in duodenal ulcer patients. J Clin Pathol 1979, 32, 171–178
- Sumii K, Yokoyama Y, Matsui Y, et al. The increased antral gastrin content and its release in response to test meal in patients with duodenal ulcer. Hiroshima J Med Sei 1979, 28, 221–227
- Taylor IL, Dockray GJ, Calam J, Walker RJ. Big and little gastrin responses to food in normal and ulcer subjects. Gut 1979, 20, 957–962
- Stadil F, Steen J. Gastrins and duodenal ulcer disease. Miyoshi A, ed. In: Gut peptides and ulcer. Proceedings of the Hiroshima Symposium on Gut Peptides and Ulcer, Hiroshima, Japan, March 31 April 1, 1982. Biomedical Research Foundation, Tokyo, 1983
- Inoue S, Nakagawa T. Gastrin response to protein test meal in gastric diseases. Tohoku J Exp Med 1980, 132, 61–67
- Trudeau WL, McGuigan JE. Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N Engl J Med 1971, 284, 408–412
- Wesdorp RIC, Fischer JE. Plasma-gastrin and acid secretion in patients with peptic ulceration. Lancet 1974, 2, 857–860
- Gedde-Dahl D. Radioimmunoassay of gastrin. Fasting serum levels in humans with normal and high gastric acid secretion. Scand J Gastroenterol 1974, 9, 41–47
- Blair AJ, Feldman M, Barnett C, Walsh JH, Richardson CT. Detailed comparison of basal and food stimulated gastric acid secretion rates and serum gastrin concentrations in duodenal ulcer patients and normal subjects. J Clin Invest 1987, 79, 582–587
- Poulsen J, Lovgreen NA, Amdrup E. Fasting and food-stimulated serum gastrin concentration in 151 duodenal ulcer patients and 41 non-dyspeptic volunteers. Scand J Gastroenterol 1986, 21, 881–885
- Barbezat GO, Grant B, Bank S, Vinik A. The effect of histamine H2-receptor blockade with metiamide on serum gastrin levels in man. Gut 1975, 16, 186–187
- Richardson CT. Effect of H2-receptor antagonists on gastric acid secretion and serum gastrin concentration. Gastroenterology 1978, 74, 366–370
- Bank S, Barbezat GO, Vinik AI, Helman C. Serum gastrin levels before and after 6 weeks of Cimetidine therapy in patients with duodenal ulcer. Digestion 1977, 15, 157–161
- Sewing KF, Hagie L, Ippoliti AF, Isenberg JI, Samloff IM, Sturdevant RAL. Effect of one month treatment with cimetidine on gastric secretion and serum gastrin and pepsinogen levels. Gastroenterology 1978, 74(suppl), 376–379
- Forrest JÄH, Fettes MR, McLoughlin GP, Heading RC. Effect of long-term cimetidine on gastric acid secretion, serum gastrin and gastric emptying. Gut 1979, 20, 404–407
- Hansky J, Stern AI, Korman MG, Waugh J. Effects of long-term cimetidine on serum gastrin in duodenal ulcer. Dig. Dis Sei 1979, 24, 468–470.
- Spence RW, Celestin LR, McCormack DA, Owens CJ. The effect of 3 months treatment with cimetidine on basal and ‘oxo’ stimulated serum gastrin. In: Burland WL, Simkin NA, eds. Proceedings of the 2nd International Symposium on H2-Receptor Antagonists. Excerpta Medica, Amsterdam, 1977, 163–174
- Mohammed R, Holden RJ, Hearns JB, McKibben BM, Buchanan KD, et al. Effects of eight weeks continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin. Gut 1983, 24, 61–66
- Mahachai V, Walker K, Thomson ABR. Comparison of cimetidine and ranitidine on 24 hour intragastric acidity and serum gastrin profile in patients with oesophagitis. Dig Dis Sei 1985, 30, 321–328
- Sherbanuik RW, Wensel R, Trautman A, Grace M, Lentle B, et al. Gastrin, gastric emptying, and gastro-oesophageal reflux after ranitidine. J Clin Gastroenterol 1983, 5, 239–244
- Lanzon-Miller S, Pounder RE, Hamilton MR, et al. 24 hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987, 1, 225–237
- Lam SK, Ong GB. Relationship of postprandial serum gastrin responses to sex, body weight, blood group status, familial dyspepsia, duration, and age of onset of ulcer symptoms in duodenal ulcer. Gut 1980, 21, 528–532
- Guttierrez O, Lehy T, Rene E, Gres L, Bonfils S. Epithelial cell proliferation in human fundic and antral mucosae: influence of superselective vagotomy and relationship with gastritis. Dig Dis Sei 1985, 30, 1034–1042
- Offerhaus GJA, de Stadt J, Samson G, Tytgat GN. Cell proliferation kinetics in gastric remnant. Eur J Cancer Clin Oncol 1985, 21, 73–79
- Larsson H, Carlsson E, Mattsson H, et al. Plasma gastrin and gastric enterochromaffinlike cell activation and proliferation. Gastroenterology 1986, 90, 391–399
- Spurling NW, Selway SAM, Poynter D. An evaluation of the safety of ranitidine during 7 years daily oral administration to beagle dogs. Human Toxicol 1989, 8, 23–32
- Jonsson K-A, Strom M, Bodemar G, Norrby K. Histological changes in the gastroduodenal mucosa after long-term medical treatment with cimetidine or parietal cell vagotomy in patients with juxtapyloric ulcer disease. Scand J Gastroenterol 1988, 23, 433–441
- Kekki M, Saukkonen M, Sipponen P, Varis K, Siurala M. Dynamics of chronic gastritis in the remnant after partial gastrectomy for duodenal ulcer. Scand J Gastroenterol 1980, 15, 509–512
- Giacosa A, Cheli R. Anatomic-functional behaviour of the gastric mucosa in different clinical phases (acute, quiescent, relapsing) of duodenal ulcer. Hepatogastroenterol 1982, 29, 124–126
- Villako K, Kekki M, Tamm A, et al. Epidemiology and dynamics of gastritis in a representative sample of an Estonian urban population. Scand J Gastroenterol 1982, 17, 601–607
- Kekki M, Sipponen P, Siurala M. Progression of antral and body gastritis in patients with active and healed duodenal ulcers and duodenitis. Scand J Gastroenterol 1984, 19, 382–388
- Wormsley KG. Campylobacter pylori and ulcer disease—a causal connection? Scand J Gastroenterol 1989, 24(suppl 160), 53–58
Scandinavian Journal of Gastroenterology
Volume 25, 1990 - Issue sup177